Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine Prevention in High-Frequency and Chronic Migraine: the Standard Paradigm

NCT06133491 is registered in ClinicalTrials.gov with Ki Health Partners. LLC as lead sponsor.

NCT NCT06133491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06133491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine Prevention in High-Frequency and Chronic Migraine: the Standard Paradigm
Lead sponsor
Ki Health Partners. LLC
Phase
Observational
Overall status
Active, not recruiting
Start date
October 18, 2023
Completion date
December 31, 2024
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, headache